View in EDS HTML Full Text PDF Full Text

Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity.

Saved in:
Bibliographic Details
Title: Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity.
Authors: Isnard S; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Mabanga T; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Royston L; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland., Berini CA; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Bu S; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Aiyana O; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Feng H; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Lebouché B; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Department of Family Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.; Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada., Costiniuk CT; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Cox J; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Kroemer G; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, assistance publique des hôpitaux de Paris (AP-HP), Paris, France., Durand M; Département de Microbiologie, Infectiologie et Immunologie, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Routy JP; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Division of Hematology, McGill University Health Centre, Montreal, QC, Canada.
Corporate Authors: Biobanque Québécoise de la COVID-19 (BQC-19)
Source: Frontiers in immunology [Front Immunol] 2025 Jan 06; Vol. 15, pp. 1505752. Date of Electronic Publication: 2025 Jan 06 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39835130
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Isnard+S%22">Isnard S</searchLink>; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Mabanga+T%22">Mabanga T</searchLink>; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Royston+L%22">Royston L</searchLink>; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Berini+CA%22">Berini CA</searchLink>; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Bu+S%22">Bu S</searchLink>; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Aiyana+O%22">Aiyana O</searchLink>; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Feng+H%22">Feng H</searchLink>; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Lebouché+B%22">Lebouché B</searchLink>; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Department of Family Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.; Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Costiniuk+CT%22">Costiniuk CT</searchLink>; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Cox+J%22">Cox J</searchLink>; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Kroemer+G%22">Kroemer G</searchLink>; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, assistance publique des hôpitaux de Paris (AP-HP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Durand+M%22">Durand M</searchLink>; Département de Microbiologie, Infectiologie et Immunologie, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Routy+JP%22">Routy JP</searchLink>; Inflammation and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Division of Hematology, McGill University Health Centre, Montreal, QC, Canada.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Biobanque+Québécoise+de+la+COVID-19+%28BQC-19%29%22">Biobanque Québécoise de la COVID-19 (BQC-19)</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Jan 06; Vol. 15, pp. 1505752. <i>Date of Electronic Publication: </i>2025 Jan 06 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39835130
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1505752
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1505752
    Titles:
      – TitleFull: Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Isnard S
      – PersonEntity:
          Name:
            NameFull: Mabanga T
      – PersonEntity:
          Name:
            NameFull: Royston L
      – PersonEntity:
          Name:
            NameFull: Berini CA
      – PersonEntity:
          Name:
            NameFull: Bu S
      – PersonEntity:
          Name:
            NameFull: Aiyana O
      – PersonEntity:
          Name:
            NameFull: Feng H
      – PersonEntity:
          Name:
            NameFull: Lebouché B
      – PersonEntity:
          Name:
            NameFull: Costiniuk CT
      – PersonEntity:
          Name:
            NameFull: Cox J
      – PersonEntity:
          Name:
            NameFull: Kroemer G
      – PersonEntity:
          Name:
            NameFull: Durand M
      – PersonEntity:
          Name:
            NameFull: Routy JP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 01
              Text: 2025 Jan 06
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1